A Study to Evaluate the My Hematology Oncology Patient Experience (MyHOPE™) For Multiple Myeloma (MM) Digital Care Network in Patients With MM

Stopped early · Phase 1

Conditions studied: Multiple Myeloma

In brief

NDS-MM-004 is a multi-center, randomized, pilot trial to evaluate the MyHOPE for multiple myeloma (MM) Platform in patients with MM. The MyHOPE for MM Platform is a validated investigational device manufactured by Amalgam Rx, Inc. and designed to provide patients with a comprehensive set of tools and resources to support the patient throughout their overall experience with MM.

Key facts

Study ID

NCT04730505

Run by

Celgene

People needed

2

Starts

2021-02-04

Expected to finish

2021-06-21

Last updated by the study team

2021-08-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is ≥ 18 years old with a diagnosis of Multiple Myeloma
• Patient must reside in the USA.
• Patients within each of the following subgroups, at one of the following timepoints, will be eligible for entry:
• Newly-diagnosed multiple myeloma transplant-eligible
• Patients undergoing their first ASCT
• Newly-diagnosed multiple myeloma transplant-ineligible
• Relapsed and/or refractory.

You may not qualify if…

• Patient has a condition(s) that, in the opinion of the Investigator, would make participation infeasible such as inability to provide informed consent, illiteracy, or inability to speak, read, and write in English.
• Patient is on hospice.
• Patient is receiving or has received an investigational agent < 28 days prior to randomization or during this pilot study.

Where it is running

• Mitchell Cancer Center, University of South Alabama — Mobile, Alabama, United States
• Mayo Cliinic - Scottsdale — Scottsdale, Arizona, United States
• University of Arizona — Tucson, Arizona, United States
• James R Berenson MD Inc — West Hollywood, California, United States
• Mayo Clinic - Jacksonville — Jacksonville, Florida, United States
• Cancer Specialists of North Florida - Jacksonville — Jacksonville, Florida, United States
• Winship Cancer Institute of Emory University — Atlanta, Georgia, United States
• Augusta University - Georgia Cancer Center — Augusta, Georgia, United States
• Innovation Clinical Research of the Pacific — Honolulu, Hawaii, United States
• Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana, United States
• American Oncology Partner Maryland — Bethesda, Maryland, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• Dana Farber Cancer Institute — Boston, Massachusetts, United States
• Western Michigan Cancer Center — Kalamazoo, Michigan, United States
• Newland Medical Associates, PC — Southfield, Michigan, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Hattiesburg Clinic — Hattiesburg, Mississippi, United States
• Icahn School of Medicine at Mount Sinai — New York, New York, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States
• NY Cancer and Blood Specialists — Port Jefferson Station, New York, United States
• Rochester General Hospital - Lipson Cancer Institute — Rochester, New York, United States
• University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
• Duke University Medical Center — Durham, North Carolina, United States
• Cone Health Cancer Center — Greensboro, North Carolina, United States
• Wake Forest Baptist Health — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.